• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Association between soluble angiotensin-converting enzyme 2 in saliva and SARS-CoV-2 infection: a cross-sectional study

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Apr 12;13(1):5985.
doi: 10.1038/s41598-023-31911-2.
Association between soluble angiotensin-converting enzyme 2 in saliva and SARS-CoV-2 infection: a cross-sectional study


Samuel Bru[SUP] #[/SUP][SUP] 1 [/SUP], Pedro Brotons[SUP] #[/SUP][SUP] 2 3 4 [/SUP], Iolanda Jordan[SUP] 5 6 7 [/SUP], Laia Alsina[SUP] 5 8 [/SUP], Desiree Henares[SUP] 5 6 [/SUP], Reyes Carballar[SUP] 1 [/SUP], Mariona Fernandez de Sevilla[SUP] 5 9 [/SUP], Irene Barrabeig[SUP] 6 10 [/SUP], Victoria Fumado[SUP] 11 [/SUP], Bàrbara Baro[SUP] 12 [/SUP], Joan Marc Martínez-Láinez[SUP] 1 [/SUP], Juan J Garcia-Garcia[SUP] 5 6 9 [/SUP], Quique Bassat[SUP] 5 6 9 12 13 14 [/SUP], Albert Balaguer[SUP] 15 [/SUP], Josep Clotet[SUP] 1 [/SUP], Cristian Launes[SUP] #[/SUP][SUP] 5 6 9 [/SUP], Carmen Muñoz-Almagro[SUP] #[/SUP][SUP] 5 15 6 [/SUP]



Affiliations

Abstract

This study aimed to investigate the association between saliva soluble angiotensin-converting enzyme 2 (sACE2) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adults. We selected a convenience sample of adults with post-acute SARS-CoV-2 infection and their household children living in quarantined family households of the metropolitan Barcelona region (Spain) during the spring 2020 pandemic national lockdown. Participants were tested for saliva sACE2 quantification by western blot and nasopharyngeal SARS-CoV-2 RT-PCR detection. A total of 161 saliva samples [82 (50.9%) from children; 79 (49.1%) from females] yielded valid western blot and RT-PCR results. Saliva sACE2 was detected in 79 (96.3%) children and 76 (96.2%) convalescent adults. Twenty (24.4%) children and 20 (25.3%) convalescent adults were positive for SARS-CoV-2 in nasopharynx by RT-PCR. SARS-CoV-2 RT-PCR-negative children had a significantly higher mean proportional level of saliva sACE2 (0.540 × 10[SUP]-3[/SUP]%) than RT-PCR-positive children (0.192 × 10[SUP]-3[/SUP]%, p < 0.001) and convalescent adults (0.173 × 10[SUP]-3[/SUP]%, p < 0.001). In conclusion, children negative for nasopharyngeal SARS-CoV-2 RT-PCR appear to exhibit a higher concentration of saliva sACE2 than SARS-CoV-2 RT-PCR-positive children and convalescent adults. Release of adequate levels of sACE2 in saliva could play a protective role against SARS-CoV-2.
 
Back
Top Bottom